GlobeNewswire

Kraig Labs Advances Commercial Spider Silk Production with New Customer Shipments and New Silkworm Research
05/11/2026
DENVER, Nov. 05, 2026 (GLOBE NEWSWIRE) -- ( 247MarketNews )— Kraig Biocraft Laboratories (OTCQB: KBLB) recently shipped its first commercial order of recombinant spider silk yarn to a globally recognized sportswear [...]
Zealand Pharma conference call on Nov 12 at 2pm CET (8am ET) to present third quarter 2026 financial results
05/11/2026
Press Release – No. 22 / 2026 Zealand Pharma conference call on Nov 12 at 2pm CET (8am ET) to present third quarter 2026 financial results Copenhagen, Denmark, November 5, 2026 – Zealand Pharma A/S (Nasdaq: ZEAL) (CVR- [...]
Genmab Announces Financial Results for the Nine Months of 2026
05/11/2026
November 5, 2026 Copenhagen, Denmark; Interim Report for the Nine Months Ended September 30, 2026 Highlights Epcoritamab approved in Europe (as TEPKINLY ® ) and Japan (as EPKINLY ® ) in combination with R² for the [...]
Osteal Therapeutics Announces Three Scientific Presentations Related to the APEX Clinical Trial Program at the 2026 AAHKS Annual Meeting
05/11/2026
Presentations will address 24-month treatment outcomes, systemic antibiotic exposure, and new treatment strategies for recalcitrant periprosthetic joint infection DALLAS, Nov. 05, 2026 (GLOBE NEWSWIRE) -- Osteal [...]
Dyne Therapeutics Reports Third Quarter 2026 Financial Results and Recent Business Highlights
05/11/2026
- Biologics License Application (BLA) for z-rostudirsen in exon 51 Duchenne muscular dystrophy (DMD) under priority review by FDA; PDUFA target action date of January 21, 2027 - - Additional one-year clinical data from [...]
Cronos Group Reports 2026 Third Quarter Results
05/11/2026
Organically achieved record net revenue, gross profit, and Adjusted EBITDA while reducing share count Net revenue in Q3 20 26 increased by 73% year-over-year on an organic, constant-currency basis Generated record net [...]
Medicus Pharma to Present at BIO-Europe 2026
05/11/2026
Medicus Chief Medical Officer will Highlight Company’s Focus on Precision Oncology, Anchored by CD228V targeted ADC and Partner Ready Therapeutic Programs PHILADELPHIA, Nov. 05, 2026 (GLOBE NEWSWIRE) -- Medicus Pharma [...]
Collegium Reports Third Quarter 2026 Financial Results; Reaffirms 2026 Guidance
05/11/2026
– Generated Record Quarterly Net Revenues of $216.3 Million, Up 3% Year-over-Year – – Generated Record JORNAY PM ® Quarterly Net Revenue of $51.9 Million, Up 24% Year-over-Year – – Generated AZSTARYS ® Quarterly Net [...]
SAB BIO Reports Q3 2026 Financial Results and Provides Business Highlights
05/11/2026
Adult and adolescent cohorts fully enrolled in registrational SAFEGUARD study of SAB-142; Pediatric cohort (ages 5–11) actively enrolling with overall enrollment on track for completion in Q4 2026 Received FDA Fast [...]
Cabaletta Bio Reports Third Quarter 2026 Financial Results and Provides Business Update
05/11/2026
RESET-Myositis ® registrational adult topline results anticipated in 2H27 with BLA submission in 1Q28, including Phase 1/2 juvenile dermatomyositis data for potential PRV eligibility and Phase 1/2 adult durability data [...]
AVITA Medical Announces National Medicare Physician Payment Framework and Simplified Billing Codes for RECELL Procedures in 2027
05/11/2026
CMS finalizes nationally published physician valuations; CMS’s four-code structure simplifies procedure reporting beginning January 1, 2027 VALENCIA, Calif., Nov. 05, 2026 (GLOBE NEWSWIRE) -- AVITA Medical ® , Inc. ( [...]
Vericel Reports Third Quarter 2026 Financial Results and Raises Full-Year Financial Guidance
05/11/2026
Total Revenue Growth of 26% to $85.4 Million Net Income Increased 179% to $14.2 Million Adjusted EBITDA Margin of 30% Raised Full-Year Revenue Guidance to $344 to $346 Million and Adjusted EBITDA Margin Guidance to 28% [...]
Tangram annonce la présentation orale des données précliniques sur le TGM-148, mettant en évidence son mécanisme d’action dépendant du contexte, à l’occasion du congrès annuel 2026 de l’American Society of Hematology (ASH)
05/11/2026
Le TGM-148 stimule la génération de thrombine dans un contexte d’altération de l’hémostase Aucun signe de risque thrombotique n’a été observé lors d’une étude toxicologique à doses répétées menée chez des primates non [...]
Intellia Therapeutics Announces Third Quarter 2026 Financial Results and Business Updates
05/11/2026
On track to complete lonvo-z commercial readiness efforts in advance of March 10, 2027 PDUFA date New lonvo-z patient perspectives and Phase 1/2 durability data to be included in investor webcast and multiple [...]
Filana Therapeutics Reports Q3 2026 Financial Results and Provides Business Update
05/11/2026
– Patient screening in Phase 2a study of simufilam in TSC-related epilepsy expected to begin by Q1 2027, following recent lift of FDA clinical hold – Recent publication in Cells 1 provides new insights into simufilam’s [...]
electroCore to Participate in the Canaccord Genuity MedTech, Diagnostics and Digital Health & Services Forum
05/11/2026
ROCKAWAY, N.J., Nov. 05, 2026 (GLOBE NEWSWIRE) -- electroCore, Inc. (Nasdaq: ECOR), a commercial-stage bioelectronic medicine and wellness company, announced today that management will participate in the Canaccord [...]
Forward Therapeutics Announces U.S. FDA IND Clearance to Initiate Phase 2 Study of FT2109 in Psoriatic Arthritis
05/11/2026
BOSTON, Nov. 05, 2026 (GLOBE NEWSWIRE) -- Forward Therapeutics, Inc. (“Forward” or the “Company”), a clinical-stage biotechnology company developing oral small molecule therapies for inflammation-driven diseases, today [...]
Processa Pharmaceuticals to Participate in Upcoming Investor Conferences
05/11/2026
VERO BEACH, FL, Nov. 05, 2026 (GLOBE NEWSWIRE) -- Processa Pharmaceuticals, Inc. (Nasdaq: PCSA) (“Processa” or the “Company”), a clinical-stage pharmaceutical company advancing differentiated therapeutic programs for [...]
Corbus Pharmaceuticals to Participate in Upcoming Investor Conferences in November
05/11/2026
NORWOOD, Mass., Nov. 05, 2026 (GLOBE NEWSWIRE) -- Corbus Pharmaceuticals Holdings, Inc. (Nasdaq: CRBP), a clinical-stage company focused on oncology and obesity, today announced that Yuval Cohen, Ph.D., Chief Executive [...]

Pages

Other news

Test 2

Lorem ipsum

Test 1

Lorem upsum